featured-image

Nuvalent ( NASDAQ: NUVL ) has announced the pricing of an upsized underwritten public offering of 5 million shares of Class A common stock at $100.00 a share, for an expected gross proceeds to be approximately $500.0 million.

The offering was upsized from the previously.

Back to Health Page